Stockreport

QIAGEN Launches Predictive Therascreen Pitx2 Test in Europe to Guide Treatment in High-Risk Breast Cancer

Qiagen N.V. Common Shares  (QGEN) 
Last qiagen n.v. common shares earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corporate.qiagen.com/investor-relations
PDF Novel DNA methylation assay provides insights for individualized chemotherapy selection HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: [Read more]